₹ 18,546.00
149.00 (0.81%)
N
Neuland Laboratories
₹ 18,546.00
NEULANDLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
23,794
PE Ratio
64.90
PB Ratio
12.62
Dividend Yield
0.18%
ROE
19.42%
ROCE
23.11%
Book Value (₹)
1,460.31
Face Value (₹)
10.00
Analyse NEULANDLAB with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 32.68% | 32.64% | 32.63% | 32.63% | 32.62% |
| Domestic Institutional Investors (DII) | 11.57% | 13.54% | 14.71% | 15.84% | 16.51% |
| Foreign Institutional Investors (FII) | 21.69% | 20.60% | 20.90% | 20.46% | 21.08% |
| Public Investors | 25.55% | 24.72% | 24.31% | 23.84% | 22.88% |
| Government | 0.40% | 0.40% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NEULANDLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
524558
NSE Scrip Name
NEULANDLAB
ISIN
INE794A01010



